JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2026, 75(2):E9-E15 | DOI: 10.36290/csf.2026.024

Pharmaceutical care in self-medication: ABC/VED analysis of over-the-counter antiallergic medicines

Viktoriia Oleksiivna Shapovalova1, Oleksandr Ananiyovych Nevzhoda2, Alina Olexandrivna Osyntseva3, Valentyn Valeriiovych Shapovalov1, Valerii Volodymyrovych Shapovalov3
1 Private Scientific Institution "Scientific and Research University of Medical and Pharmaceutical Law", Kyiv, Ukraine
2 Danylo Halytsky Lviv National Medical University, Lvov, Ukraine
3 Lviv Medical University, Lviv, Ukraine

Introduction: The growing prevalence of allergic diseases and the widespread use of over-the-counter (OTC) medicines necessitate rationalization of symptomatic treatment, balancing clinical relevance with limited healthcare resources.

Aim: To evaluate OTC medicines used for symptomatic allergy treatment through ABC/VED analysis in order to identify priority medicines and support pharmaceutical and managerial decision-making.

Materials and methods: The study included 25 OTC medicines registered in Ukraine for symptomatic allergy treatment during 2024–2025. Aggregate sales data from pharmacy networks and distributors were analysed. ABC analysis was used to assess expenditure distribution, while VED analysis classified medicines according to clinical importance based on pharmacist protocols, clinical guidelines, pharmacological role, safety profile, and suitability for self-medication. The integrated ABC/VED matrix was applied to determine priority medicines.

Results: A limited number of medicines accounted for the majority of expenditures. Cetirizine, Loratadine, Desloratadine, Xylometazoline and Oxymetazoline formed the A/Vital category, representing the highest priority group combining economic weight with clinical relevance. The results demonstrate a strong concentration of financial resources in first-line antihistamines and essential topical agents used for rapid symptom relief in self-medication.

Conclusion: The integrated ABC/VED approach is an effective tool for identifying priority OTC antiallergic medicines, supporting rational pharmacy assortment management, supporting evidence-based practice and pharmaceutical care in self-medication under limited healthcare resources.

Keywords: allergy, self-medication, pharmaceutical care, OTC medicines, ABC/VED analysis

Accepted: May 27, 2026; Published: June 10, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Shapovalova VO, Ananiyovych Nevzhoda O, Osyntseva AO, Valeriiovych Shapovalov V, Volodymyrovych Shapovalov V. Pharmaceutical care in self-medication: ABC/VED analysis of over-the-counter antiallergic medicines. Čes. slov. farm. 2026;75(2):E9-15. doi: 10.36290/csf.2026.024.
Download citation

References

  1. World Health Organization. The selection and use of essential medicines: executive summary of the report of the 24th WHO expert committee. Geneva: World Health Organization; 2023. https://www.who.int/publications/i/item/WHO-MHP-HPS-EML-2023.01.
  2. International Pharmaceutical Federation. FIP Development Goals - Good Pharmacy Services Vision 2020. The Hague: International Pharmaceutical Federation; 2020. https://www.fip.org/files/content/pharmacy-practice/community-pharmacy/CPS_Vision_2020.pdf.
  3. Yadav P. Health product supply chains in developing countries: diagnosis of the root causes of underperformance and an agenda for reform. Health Systems & Reform. 2015;1(2):142-154. https://doi.org/10.4161/23288604.2014.968005. Go to original source... Go to PubMed...
  4. Propisnova V, Misiurova S. Adherence to the pharmacist's protocol of sore throat symptomatic treatment in Ukraine and problems of harmonization with international guidelines. Ceska a Slovenska Farmacie. 2025;74(1):E1-E10. https://doi.org/10.36290/csf.2025.002 Go to original source... Go to PubMed...
  5. Simons FER. Advances in H1-antihistamines. New England Journal of Medicine. 2004;351(21):2203-2217. https://doi.org/10.1056/NEJMra033121. Go to original source... Go to PubMed...
  6. Björnsdóttir US, Deleuran M, Janson C, Mäkelä M, Aanaes K, Porsbjerg C, Toppila-Salmi S, Agner T, Ahlbeck L, Altraja A, Bjermer L, Bradley M, Cardell LO, Dahlén SE, Eyerich K, Hedlin G, Nystrøm TH, Jørstad SØ, Kankaanranta H, Karjalainen J, Korhonen L, Lehtimäki L, Mandelin J, Remitz A, Sonesson A, Steinsvåg S, Thomsen SF, Suppli Ulrik CSU, Vestergaard C, Thyssen JP. Clinical relevance of type 2 inflammation as a driver of multi-organ disease: A Delphi consensus initiative. Allergy. 2021;76(S110):1059. https://doi.org/10.1111/all.15098 Go to original source...
  7. Global Initiative for Asthma. Global strategy for asthma management and prevention, 2023. https://ginasthma.org.
  8. Ministry of Health of Ukraine. Order No. 7 of January 5, 2022. Protocols of the pharmacist for dispensing medicines without prescription "Symptomatic treatment of allergy". https://zakon.rada.gov.ua/rada/show/v0007282-22.
  9. World Health Organization. Introduction to drug utilization research. Geneva: World Health Organization; 2003. https://apps.who.int/iris/handle/10665/42627.
  10. Simoens S. Health economic assessment: a methodological primer. International Journal of Environmental Research and Public Health. 2009;6(12):2950-2966. https://doi.org/10.3390/ijerph6122950. Go to original source... Go to PubMed...
  11. Management Sciences for Health. Managing access to medicines and health technologies. Chapter 40: Analyzing and controlling pharmaceutical expenditures (ABC and VEN methods). Arlington: Management Sciences for Health; 2012. https://msh.org/wp-content/uploads/2013/04/mds3-ch40-expenditures-mar2012.pdf.
  12. Singh J, Singh J. Pharmacotherapeutic options for treatment of insomnia. International Journal of Basic and Clinical Pharmacology. 2014;3(5). https://doi.org/10.5455/2319-2003.ijbcp20141035. Go to original source...
  13. Deressa MB, Beressa TB, Jemal A. Analysis of pharmaceuticals inventory management using ABC-VEN matrix analysis in selected health facilities of West Shewa Zone, Oromia Regional State, Ethiopia. Integrated Pharmacy Research and Practice. 2022;11:47-59. https://doi.org/10.2147/IPRP.S354810. Go to original source... Go to PubMed...
  14. Verma H, Sankdia RK, Lahare L, Dubey L. ABC-VED Analysis of Drugs Procured in the Drug Store of a Tertiary Care Teaching Hospital. Journal of Pharmacy and Bioallied Sciences. 2025;17(Suppl 3):S2810-S2812. https://doi.org/10.4103/jpbs.jpbs_757_25. Go to original source...
  15. Meena DK, Mathaiyan J. Assessment of drug inventory using ABC-VED matrix analysis in selected public health facilities of Puducherry, India. Journal of Family Medicine and Primary Care. 2025;14(4):1389-1394. https://doi.org/10.4103/jfmpc.jfmpc_1544_24. Go to original source... Go to PubMed...
  16. Reid IA, Hussain M, Osman S, Bakheet S. Strengthening local pharmaceutical manufacturing to address medicine shortages in post-war: Sudan. Discover Health Systems. 2025;4:109. https://doi.org/10.1007/s44250-025-00299-3. Go to original source...
  17. Hayduchok IG, Shapovalova VO, Ishcheikin KE, Chopyak VV, Shapovalov VV Jr, Shapovalov VV. Pharmacoeconomic approaches for pharmacotherapy of rheumatoid arthritis. Likarska Sprava. 2021;(1-2):70-79. https://doi.org/10.31640/JVD.1-2.2021(11). Go to original source...
  18. Nevzghoda OA, Shapovalov VV, Osyntseva AO, et al. Optimisation of antibiotic selection: ABC and VED analysis of medicines against intracellular microorganisms. Tuberculosis Pulmonary Diseases HIV Infection. 2025;3(62):68-79. https://doi.org/10.30978/TB2025-3-68. Go to original source...
  19. Nevzghoda O, Osyntseva A, Shapovalova V, Titarenko I, Shapovalov V, Dovzhuk V, Shapovalov V. Optimization of pharmacotherapy for chronic pancreatitis: use of ABC/VED analysis in marketing and pharmacoeconomic studies. Proceedings of the Shevchenko Scientific Society Medical Sciences. 2025;77(1):1-14. https://doi.org/10.25040/ntsh2025.01.16. Go to original source...




Czech and Slovak Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.